Elevance Health (ELV) Free Cash Flow (2010 - 2026)

Elevance Health (ELV) has 17 years of Free Cash Flow data on file, last reported at $1.6 billion in Q2 2026.

• On a quarterly basis, Free Cash Flow fell 9.01% year-over-year to $1.6 billion in Q2 2026; TTM through Jun 2026 was $6.3 billion, a 17.84% increase from a year earlier, with the FY2025 full-year figure at $3.2 billion, down 30.27% from the prior year.
• Free Cash Flow for Q2 2026 stood at $1.6 billion, down from $4.1 billion in the prior quarter.
• Over the last five years, Free Cash Flow for ELV reached as high as $6.2 billion in Q1 2023 and fell as low as -$3.3 billion in Q4 2023.
• Historically, Free Cash Flow has averaged $1.5 billion across 5 years, with a median of $1.7 billion in 2024.
• Across the five-year window, Free Cash Flow tumbled 236.34% in 2022 and surged 1341.13% in 2025, its largest moves.
• Year by year, Free Cash Flow stood at -$1.8 billion in 2022, then sank by 81.55% to -$3.3 billion in 2023, then soared by 111.65% to $384.0 million in 2024, then plunged by 154.43% to -$209.0 million in 2025, then soared by 877.99% to $1.6 billion in 2026.
• Per Business Quant data, the three most recent Free Cash Flow figures were $1.6 billion in Q2 2026, $4.1 billion in Q1 2026, and -$209.0 million in Q4 2025.